ENTITY

Immix Biopharma Inc (IMMX US)

39
Analysis
Health CareUnited States
Immix Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel class of tissue-specific therapeutics in oncology and inflammation to treat inflammatory bowel disease, including ulcerative colitis and crohn's diseases. Immix Biopharma serves customers in the United States.
more
Company Event26 Mar 2026 04:00 • Upcoming
Add To Calendar
Company Event08 Nov 2025 05:00 • Upcoming
Add To Calendar
Company Event08 Aug 2025 19:00 • Upcoming
Add To Calendar
Company Event30 Jun 2025 19:00 • Upcoming
Add To Calendar
Company Event04 Jun 2025 03:00 • Latest
x